News from Accentus Medical

The STS Group is proud to announce its acquisition of Accentus Medical

The STS Group is proud to announce its acquisition of Accentus Medical which begins an exciting new chapter in the growth story of the STS Group and Accentus Medical

Accentus Medi...

Accentus Medical’s Acusure® Titanium Coating Applied to Breakthrough Spinal Device

Accentus Medical is pleased to announce the clinical application of its Acusure®^{^®} thermal plasma spray titanium coating to the MOTUS Total Joint Replacement device developed by U...

Accentus Medical launches Combined Agluna® – Acusure Ag® Silver Antimicrobial Surface Technologies

Accentus Medical is pleased to announce the unique combined application of its proprietary Agluna® and Acusure Ag®®^{^®} silver ion based antimicrobial surface technologies. The tech...

Agluna® Antimicrobial Surface Technology Surpasses 2,000 Custom Clinical Device Applications

Accentus Medical is pleased to announce the application of its proprietary Agluna^{^®} silver ion based antimicrobial surface treatment to in excess of 2,000 custom patient specific ...

AAOS 2022

Accentus Medical will be attending annual meeting of American Academy of Orthopaedic Surgeons, Chicago, 22-26 March.

We look forward to updating with existing international custom...